The guanylate cyclase stimulator BAY 41-2272 does not prevent right ventricular hypertrophy and failure alone or in combination with sildenafil

被引：0
|
作者：
Andersen, A. [1 ]
Nielsen, J. M. [1 ]
Holmboe, S. [1 ]
Vildbrad, M. D. [1 ]
Nielsen-Kudsk, J. E. [1 ]
机构：
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] Effect of Bay 41-2272, a Soluble Guanylate Cyclase Agonist, in Lymphocytes
    Wall Barbosa de Carvalho, Marina Uchoa
    Ferreira Rosa, Paola Vendramini
    Soeiro Pereira, Paulo Vitor
    Antunes, Edson
    Condino Neto, Antonio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S54 - S54
  • [2] Effect of BAY 41-2272, a soluble guanylate cyclase agonist, in lymphocytes
    Uchoa Wall Barbosa de Carvalho, M.
    Vendramini Ferreira Rosa, P.
    Soeiro Pereira, P., V
    Antunes, E.
    Condino Neto, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 137 - 137
  • [3] Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
    Boerrigter, G
    Costello-Boerrigter, LC
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Lapp, H
    Stasch, JP
    Burnett, JC
    CIRCULATION, 2003, 107 (05) : 686 - 689
  • [4] BAY 41-2272, a Soluble Guanylate Cyclase Stimulator, Relaxes Isolated Human Ureter in a Standardized In Vitro Model
    Miyaoka, Ricardo
    Mendes, Camila
    Schenka, Andre
    Gonzalez, Paulo Gabriel
    de Nucci, Gilberto
    Antunes, Edson
    Monga, Manoj
    D'Ancona, Carlos Arturo Levi
    Monica, Fabiola Zakia
    UROLOGY, 2014, 83 (01) : 256.e1 - 256.e7
  • [5] Effect of BAY 41-2272, a Soluble Guanylate Cyclase Agonist, in Human Lymphocytes
    Carvalho, Marina
    Vendramini, Paola
    Soeiro Pereira, Paulo Vtor
    Neto, Antonio Condino
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S53 - S53
  • [6] Cardiorenal actions of the novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure in comparison to nitroglycerin
    Boerrigter, G
    Costello-Boerrigter, LC
    Lapp, H
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Stasch, JP
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 253A - 254A
  • [7] THE ROLE OF SOLUBLE GUANYLATE CYCLASE STIMULATOR BAY 41-2272 ON REMODELLING PROCESSES RELEVANT TO THE PATHOGENESIS OF PULMONARY ARTERIAL HYPERTENSION
    Shao, D.
    Wort, S. J.
    THORAX, 2014, 69 : A22 - A23
  • [8] BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes
    Soeiro-Pereira, P. V.
    Falcai, A.
    Kubo, C. A.
    Oliveira-Junior, E. B.
    Marques, O. C.
    Antunes, E.
    Condino-Neto, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (05) : 1617 - 1630
  • [9] BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats
    Deruelle, Philippe
    Balasubramaniam, Vivek
    Kunig, Anette M.
    Seedorf, Gregory J.
    Markham, Neil E.
    Abman, Steven H.
    BIOLOGY OF THE NEONATE, 2006, 90 (02): : 135 - 144
  • [10] Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon
    Cosyns, Sarah M. R.
    Lefebvre, Romain A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 686 (1-3) : 104 - 115
12345